Rhabdomyosarcoma Masquerading as Acute Leukemia

被引：16

作者：

Shinkoda, Yuichi

Nagatoshi, Yoshihisa ^{[1
]}

Fukano, Reiji

Nishiyama, Kenichi ^{[2
]}

Okamura, Jun ^{[3
]}

机构：

[1] Kyushu Natl Canc Ctr, Sect Pediat, Minami Ku, Fukuoka 8111395, Japan

[2] Kyushu Natl Canc Ctr, Dept Pathol, Fukuoka 8111395, Japan

[3] Kyushu Natl Canc Ctr, Inst Clin Res, Fukuoka 8111395, Japan

来源：

PEDIATRIC BLOOD & CANCER | 2009年 / 52卷 / 02期

关键词：

bone marrow involvement; immunohistochemistry; rhabdomyosarcoma; FUSION; GENE;

D O I：

10.1002/pbc.21783

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Rhabdomyosarcoma (RMS) masquerading as acute leukemia (AL) is very rare. We describe three cases with RMS without any symptoms of solid tumors. Bone marrow (BM) showed approximately 95% of blast-like abnormal cells, lacking almost all of the Surface antigens of myeloid- and lymphoid-lineage. The immunohistochemistry revealed positive of the cells for actin, desmin and myoglobin. it is important to examine BM samples by immunohistochemistry, when a flow cytometric analysis reveals an Unusual presentation. Pediatr Blood Cancer 2009;52:286-287. (C) 2008 Wiley-Liss, Inc.

引用

收藏

页码：286 / 287

页数：2

相关论文

共 10 条

[1]

Borowitz M, 2001, WHO CLASSIFICATION T, P106

[2] Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma - A report from the intergroup rhabdomyosarcoma study IV [J].

Breneman, JC ;

Lyden, E ;

Pappo, AS ;

Link, MP ;

Anderson, JR ;

Parham, DM ;

Qualman, SJ ;

Wharam, MD ;

Donaldson, SS ;

Maurer, HM ;

Meyer, WH ;

Baker, KS ;

Paidas, CN ;

Crist, WM .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (01) :78-84

[3] European Intergroup Studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: Final results and analysis of prognostic factors [J].

Carli, M ;

Colombatti, R ;

Oberlin, O ;

Bisogno, G ;

Treuner, J ;

Koscielniak, E ;

Tridello, G ;

Garaventa, A ;

Pinkerton, R ;

Stevens, M .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (23) :4787-4794

[4]

DAVIS RJ, 1994, CANCER RES, V54, P2869

[5] RHABDOMYOSARCOMA, PRESENTING AS DISSEMINATED MALIGNANCY FROM AN UNKNOWN PRIMARY SITE - A RETROSPECTIVE STUDY OF 10 PEDIATRIC CASES [J].

ETCUBANAS, E ;

PEIPER, S ;

STASS, S ;

GREEN, A .

MEDICAL AND PEDIATRIC ONCOLOGY, 1989, 17 (01) :39-44

[6] FUSION OF A FORK HEAD DOMAIN GENE TO PAX3 IN THE SOLID TUMOR ALVEOLAR RHABDOMYOSARCOMA [J].

GALILI, N ;

DAVIS, RJ ;

FREDERICKS, WJ ;

MUKHOPADHYAY, S ;

RAUSCHER, FJ ;

EMANUEL, BS ;

ROVERA, G ;

BARR, FG .

NATURE GENETICS, 1993, 5 (03) :230-235

[7] Donor leukocyte infusion after allogeneic bone marrow transplantation was not effective for relapsed rhabdomyosarcoma [J].

Moritake, H ;

Ikuno, Y ;

Tasaka, H ;

Koga, H ;

Miyazaki, S ;

Okamura, J .

BONE MARROW TRANSPLANTATION, 1998, 21 (07) :725-726

[8]

RUYMANN FB, 1984, CANCER, V82, P349

[9] PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma:: A report from the children's oncology group [J].

Sorensen, PHB ;

Lynch, JC ;

Qualman, SJ ;

Tirabosco, R ;

Lim, JF ;

Maurer, HM ;

Bridge, JA ;

Crist, WM ;

Triche, TJ ;

Barr, FG .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (11) :2672-2679

[10]

Varma N., 1993, Indian Journal of Pediatrics, V60, P316, DOI 10.1007/BF02822201